| A Randomized Trial of Protocol-Based Care for Early Septic Shock ADC Yealy DM, Kellum JA, Huang DT, Barnato AE, Weissfeld LA, Pike F ... NEJM 370 (18), 1683-93, 2014 | 2927* | 2014 |
| Viral epitope profiling of COVID-19 patients reveals cross-reactivity and correlates of severity E Shrock, E Fujimura, T Kula, RT Timms, IH Lee, Y Leng, ML Robinson, ... Science 370 (6520), eabd4250, 2020 | 647 | 2020 |
| FcγR-mediated SARS-CoV-2 infection of monocytes activates inflammation C Junqueira, Â Crespo, S Ranjbar, LB De Lacerda, M Lewandrowski, ... Nature 606 (7914), 576-584, 2022 | 489 | 2022 |
| Effect of hydroxychloroquine on clinical status at 14 days in hospitalized patients with COVID-19: a randomized clinical trial WH Self, MW Semler, LM Leither, JD Casey, DC Angus, RG Brower, ... Jama 324 (21), 2165-2176, 2020 | 467 | 2020 |
| Procalcitonin-guided use of antibiotics for lower respiratory tract infection DT Huang, DM Yealy, MR Filbin, AM Brown, CCH Chang, Y Doi, ... New England Journal of Medicine 379 (3), 236-249, 2018 | 459 | 2018 |
| An immune-cell signature of bacterial sepsis M Reyes, MR Filbin, RP Bhattacharyya, K Billman, T Eisenhaure, ... Nature medicine 26 (3), 333-340, 2020 | 353 | 2020 |
| The failed intubation attempt in the emergency department: analysis of prevalence, rescue techniques, and personnel AE Bair, MR Filbin, RG Kulkarni, RM Walls The Journal of emergency medicine 23 (2), 131-140, 2002 | 261 | 2002 |
| Longitudinal proteomic analysis of severe COVID-19 reveals survival-associated signatures, tissue-specific cell death, and cell-cell interactions MR Filbin, A Mehta, AM Schneider, KR Kays, JR Guess, M Gentili, ... Cell Reports Medicine 2 (5), 2021 | 229 | 2021 |
| Clinical trial: comparative effectiveness of cephalexin plus trimethoprim-sulfamethoxazole versus cephalexin alone for treatment of uncomplicated cellulitis: a randomized … DJ Pallin, WD Binder, MB Allen, M Lederman, S Parmar, MR Filbin, ... Clinical infectious diseases 56 (12), 1754-1762, 2013 | 176 | 2013 |
| Presenting symptoms independently predict mortality in septic shock: importance of a previously unmeasured confounder MR Filbin, J Lynch, TD Gillingham, JE Thorsen, CL Pasakarnis, S Nepal, ... Critical care medicine 46 (10), 1592-1599, 2018 | 151 | 2018 |
| Long-term host immune response trajectories among hospitalized patients with sepsis S Yende, JA Kellum, VB Talisa, OMP Palmer, CCH Chang, MR Filbin, ... JAMA network open 2 (8), e198686-e198686, 2019 | 146 | 2019 |
| Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised … WH Self, U Sandkovsky, CS Reilly, DM Vock, RL Gottlieb, M Mack, ... The Lancet Infectious Diseases 22 (5), 622-635, 2022 | 139 | 2022 |
| SARS-CoV-2 infects blood monocytes to activate NLRP3 and AIM2 inflammasomes, pyroptosis and cytokine release C Junqueira, Â Crespo, S Ranjbar, M Lewandrowski, J Ingber, ... Research square, 2021 | 137 | 2021 |
| SARS-CoV-2 viremia is associated with distinct proteomic pathways and predicts COVID-19 outcomes Y Li, AM Schneider, A Mehta, M Sade-Feldman, KR Kays, M Gentili, ... The Journal of clinical investigation 131 (13), 2021 | 129 | 2021 |
| Does the sedative agent facilitate emergency rapid sequence intubation? MLA Sivilotti, MR Filbin, HE Murray, P Slasor, RM Walls, ... Academic emergency medicine 10 (6), 612-620, 2003 | 122 | 2003 |
| Compliance with the national SEP-1 quality measure and association with sepsis outcomes: a multicenter retrospective cohort study C Rhee, MR Filbin, AF Massaro, AL Bulger, D McEachern, KA Tobin, ... Critical care medicine 46 (10), 1585-1591, 2018 | 112 | 2018 |
| Plasma ACE2 predicts outcome of COVID-19 in hospitalized patients TW Kragstrup, HS Singh, I Grundberg, ALL Nielsen, F Rivellese, A Mehta, ... PloS one 16 (6), e0252799, 2021 | 103 | 2021 |
| Endothelial permeability and hemostasis in septic shock: results from the ProCESS trial PC Hou, MR Filbin, H Wang, L Ngo, DT Huang, WC Aird, DM Yealy, ... Chest 152 (1), 22-31, 2017 | 101 | 2017 |
| Microcirculatory perfusion disturbances in septic shock: results from the ProCESS trial MJ Massey, PC Hou, M Filbin, H Wang, L Ngo, DT Huang, WC Aird, ... Critical Care 22, 1-11, 2018 | 93 | 2018 |
| Plasma from patients with bacterial sepsis or severe COVID-19 induces suppressive myeloid cell production from hematopoietic progenitors in vitro M Reyes, MR Filbin, RP Bhattacharyya, A Sonny, A Mehta, K Billman, ... Science translational medicine 13 (598), eabe9599, 2021 | 80 | 2021 |
